QIAGEN FIN 3Q16 Results
​Qiagen, the supplier of testing solutions, reported 3Q16 results that showed acceleration in organic growth, confirming the positive momentum appeared in 2Q16. Organic revenue climbed 6% yoy to $339m, at the top of the guided range. US sales of HPV, the test for cervical cancer, ceased to be a major drag, representing a headwind of only 1%. Most importantly, most other product categories saw buoyant demand,growing 7% organically, a record for many years. The company flagged the...
Spread Research is France's first Rating Agency, registered by ESMA (European Securities and Markets Authority) and a leading European Independent Credit Research firm, founded in 2004 and based in Lyon, France. Our experienced team offer key research services using a wide range of investment strategies and research methodologies for the High Yield, Emerging Markets, Convertibles and Loan Markets.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.